SARS-CoV-2 replicates using its RNA genome, which codes for several proteins essential for viral replication. Enzymes like RNA-dependent RNA polymerase (RdRp) and main protease (Mpro) are crucial for this process. These enzymes are targets for antiviral drug development, and understanding their catalytic mechanisms can help in designing inhibitors that block viral replication.
